Vilde Yuli Stenberg
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 22, 2025
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models.Rugile Liukaityte, Vilde Yuli Stenberg, Andrius Kleinauskas
|Jun 10, 2022
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001.Vilde Yuli Stenberg, Anna Julie Kjøl Tornes, Hogne Røed Nilsen
|Jun 02, 2021
Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer.Vilde Yuli Stenberg, Roy Hartvig Larsen, Li-Wei Ma
|Jan 11, 2020
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer.Vilde Yuli Stenberg, Asta Juzeniene, Qingqi Chen
Pageof 1
Frequent Collaborators
4 joint publications
Asta Juzeniene
2 joint publications
Petras Juzenas
1 joint publications
Qingqi Chen
1 joint publications
Xiaoming Yang
1 joint publications
Øyvind Sverre Bruland
1 joint publications
Anna Julie Kjøl Tornes
1 joint publications
Mona-Elisabeth Revheim
1 joint publications
Rugile Liukaityte
1 joint publications
Andrius Kleinauskas
1 joint publications
Alfonso Urbanucci
